Physician profile
Ryan Fillmore
NPI 1184043283
$753.01
in general payments reported to CMS, 2019-2025
8 companies · $262 in 2025
The $262 reported for 2025 was more than what 75% of Neurocritical Care providers received nationally (typical 2025 total: $95.82).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.07 · 2020: $12.96 · 2021: $26.74 · 2022: $124 · 2023: $293 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ceribell, INC. | $359.57 | 2023-2025 | Pocket Eeg Device, Ceribell Rapid Response Eeg |
| Chiesi USA, INC. | $151.73 | 2021-2023 | Cleviprex |
| Astrazeneca Pharmaceuticals Lp | $144.15 | 2022-2023 | Andexxa |
| Ucb, INC. | $34.07 | 2019 | |
| Janssen Biotech, INC. | $32.20 | 2025 | |
| Alexion Pharmaceuticals, INC. | $18.33 | 2025 | Ultomiris |
| Abbott Laboratories | $12.96 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Fillmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.